2020
DOI: 10.1038/s41537-020-0097-5
|View full text |Cite
|
Sign up to set email alerts
|

Overdispersed gene expression in schizophrenia

Abstract: Schizophrenia (SCZ) is a severe, highly heterogeneous psychiatric disorder with varied clinical presentations. The polygenic genetic architecture of SCZ makes identification of causal variants a daunting task. Gene expression analyses hold the promise of revealing connections between dysregulated transcription and underlying variants in SCZ. However, the most commonly used differential expression analysis often assumes grouped samples are from homogeneous populations and thus cannot be used to detect expressio… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
16
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(20 citation statements)
references
References 99 publications
3
16
0
1
Order By: Relevance
“…Alterations in glial cells (mainly microglia and astrocytes) could contribute to this neurovascular fragility ( Figure 1 ). Growing evidence place the PFC as central in this hypothesis because multiple investigations on SCZ patients found vascular defects in this particular region, ranging from decreases in claudin-5 ( Greene et al, 2018 ), reductions in VEGF signaling ( Fulzele and Pillai, 2009 ; Huang et al, 2020 ), a less dense capillary network ( Uranova et al, 2013 ), to oversimplified angioarchitecture ( Senitz and Winkelmann, 1991 ; Uranova et al, 2010 ), and other ultrastructural defects ( Figure 1 ; Webster et al, 2001 ; Uranova et al, 2010 ; Ishizuka et al, 2017 ; Hill et al, 2020 ). As many key components of NVC are impacted by SCZ, it is not surprising that one of the most consistently observed neurovascular correlates of the illness is hypo-activity in PFC regions and in the left superior temporal gyrus, as revealed by a recent systematic review of both task and resting-state fMRI cross-sectional studies in first-episode SCZ patients ( Mwansisya et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…Alterations in glial cells (mainly microglia and astrocytes) could contribute to this neurovascular fragility ( Figure 1 ). Growing evidence place the PFC as central in this hypothesis because multiple investigations on SCZ patients found vascular defects in this particular region, ranging from decreases in claudin-5 ( Greene et al, 2018 ), reductions in VEGF signaling ( Fulzele and Pillai, 2009 ; Huang et al, 2020 ), a less dense capillary network ( Uranova et al, 2013 ), to oversimplified angioarchitecture ( Senitz and Winkelmann, 1991 ; Uranova et al, 2010 ), and other ultrastructural defects ( Figure 1 ; Webster et al, 2001 ; Uranova et al, 2010 ; Ishizuka et al, 2017 ; Hill et al, 2020 ). As many key components of NVC are impacted by SCZ, it is not surprising that one of the most consistently observed neurovascular correlates of the illness is hypo-activity in PFC regions and in the left superior temporal gyrus, as revealed by a recent systematic review of both task and resting-state fMRI cross-sectional studies in first-episode SCZ patients ( Mwansisya et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…Although the expanded incidence rate and incapacitating consequences of schizophrenia, little is available regarding its pathogenesis [ 17 ]. This disorder has a heterogonous genetic nature, and gene expression evaluation may expose the association between altered expressions and the pathogenesis of schizophrenia [ 18 ]. Moreover, gene expression is supposed to be the chief way genotype principally affects the disease phenotype [ 17 ].…”
Section: Discussionmentioning
confidence: 99%
“…Studies in brain tissue from individuals with developmental disorders have also not yet implicated altered expression of these genes (e.g. Chang et al, 2015;Huang et al, 2020); however, such studies are limited by small sample sizes, by sex-biased samples, by considerable heterogeneity in donors symptoms and genetics, by post mortem considerations and by treatment effects. I hypothesise that after controlling for relevant variables (e.g.…”
Section: Discussionmentioning
confidence: 99%